PAR 6.98% 20.0¢ paradigm biopharmaceuticals limited..

research reports and media, page-1602

  1. 733 Posts.
    lightbulb Created with Sketch. 138
    Perhaps, perhaps not, nothing wrong with considering the pitfalls.

 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.